The economic burden of migraine: a nationwide cost-of-illness approach from the year 2020 European Health Survey in Spain
In Spain, persons with migraine showed a meaningful excess cost compared with persons without migraine, particularly due to labour cost component, although the economic cost to the NHS was also considerable. Given the high prevalence of migraine, its overall attributable economic impact for Spain might range between 10 394 and 14 cost 230 million Euros in year 2020.
Authors
- José Fernández‐Ferro (ORCID: https://orcid.org/0000-0003-1172-0153)
- Susana Gómez-Lus
- Carlos Ordás (ORCID: https://orcid.org/0000-0003-3551-8769)
- B Ferro-Rey
- Javier Rejas (ORCID: https://orcid.org/0000-0002-7987-360X)
- José Miguel Láinez Andrés
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Valencia Catholic University Saint Vincent Martyr (ES)
- Pathways Behavioral Services (US)
- Hospital Clínico Universitario de Valencia (ES)
- Hospital Universitario Rey Juan Carlos (ES)
- Lundbeck (Spain) (ES)
- Madrid Health Service (ES)
- Universidad Carlos III de Madrid (ES)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- Neurología (English Edition)
- Published
- 2025-06-21
- DOI
- https://doi.org/10.1016/j.nrleng.2025.06.002
- Citations
- 2
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.94